Results 151 to 160 of about 17,823 (170)

Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastoma. [PDF]

open access: yesSci Adv
Han JZR   +19 more
europepmc   +1 more source

T-Cell Engagers in Lung Cancer: A Comprehensive Literature Review from Tarlatamab Approval to Next-Generation Strategies. [PDF]

open access: yesCancers (Basel)
Saydawi A   +8 more
europepmc   +1 more source

PK/TD modeling for prediction of the effects of 8C2, an anti-topotecan mAb, on topotecan-induced toxicity in mice

International Journal of Pharmaceutics, 2014
Joseph P Balthasar, Dhaval K Shah
exaly  

Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release

European Journal of Pharmaceutics and Biopharmaceutics, 2011
Marize Campos Valadares   +2 more
exaly  

Urinary and fecal excretion of topotecan in patients with malignant solid tumours

Cancer Chemotherapy and Pharmacology, 2002
Jan H M Schellens   +1 more
exaly  

Home - About - Disclaimer - Privacy